478 related articles for article (PubMed ID: 17000658)
1. The epidermal growth factor receptor pathway: a model for targeted therapy.
Scaltriti M; Baselga J
Clin Cancer Res; 2006 Sep; 12(18):5268-72. PubMed ID: 17000658
[TBL] [Abstract][Full Text] [Related]
2. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
Wang CY; Wang YT; Tzeng DW; Yang JL
Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285
[TBL] [Abstract][Full Text] [Related]
3. Gastric mucin secretion in response to beta-adrenergic G protein-coupled receptor activation is mediated by SRC kinase-dependent epidermal growth factor receptor transactivation.
Słomiany BL; Słomiany A
J Physiol Pharmacol; 2005 Jun; 56(2):247-58. PubMed ID: 15985706
[TBL] [Abstract][Full Text] [Related]
4. Mutations and response to epidermal growth factor receptor inhibitors.
Laurent-Puig P; Lievre A; Blons H
Clin Cancer Res; 2009 Feb; 15(4):1133-9. PubMed ID: 19228718
[TBL] [Abstract][Full Text] [Related]
5. Activated EGF receptor may balance ERK-inhibitory network signalling pathways.
Hanke S; Valkova C; Stirnweiss J; Drube S; Liebmann C
Cell Signal; 2006 Jul; 18(7):1031-40. PubMed ID: 16226010
[TBL] [Abstract][Full Text] [Related]
6. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
Chen KC; Zhou Y; Zhang W; Lou MF
Mol Vis; 2007 Mar; 13():374-87. PubMed ID: 17392688
[TBL] [Abstract][Full Text] [Related]
7. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.
Dobashi Y; Suzuki S; Sugawara H; Ooi A
Hum Pathol; 2007 Jun; 38(6):914-25. PubMed ID: 17376509
[TBL] [Abstract][Full Text] [Related]
8. STAT-mediated EGFR signaling in cancer.
Quesnelle KM; Boehm AL; Grandis JR
J Cell Biochem; 2007 Oct; 102(2):311-9. PubMed ID: 17661350
[TBL] [Abstract][Full Text] [Related]
9. Activation of calcium-dependent kinases and epidermal growth factor receptor regulate muscarinic acetylcholine receptor-mediated MAPK/ERK activation in thyroid epithelial cells.
Montiel M; Quesada J; Jiménez E
Cell Signal; 2007 Oct; 19(10):2138-46. PubMed ID: 17643958
[TBL] [Abstract][Full Text] [Related]
10. Targeting the EGFR and the PKB pathway in cancer.
Klein S; Levitzki A
Curr Opin Cell Biol; 2009 Apr; 21(2):185-93. PubMed ID: 19216065
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
12. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
[TBL] [Abstract][Full Text] [Related]
13. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
[TBL] [Abstract][Full Text] [Related]
14. The EGF receptor activates ERK but not JNK Ras-dependently in basal conditions but ERK and JNK activation pathways are predominantly Ras-independent during cardiomyocyte stretch.
Duquesnes N; Vincent F; Morel E; Lezoualc'h F; Crozatier B
Int J Biochem Cell Biol; 2009 May; 41(5):1173-81. PubMed ID: 19015044
[TBL] [Abstract][Full Text] [Related]
15. Novel combinations based on epidermal growth factor receptor inhibition.
Adjei AA
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4446s-4450s. PubMed ID: 16857826
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.
Yamamoto N; Mammadova G; Song RX; Fukami Y; Sato K
J Cell Sci; 2006 Nov; 119(Pt 22):4623-33. PubMed ID: 17062641
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of normal, paramalignant, and malignant human urothelial cells to inhibitors of the epidermal growth factor receptor signaling pathway.
MacLaine NJ; Wood MD; Holder JC; Rees RW; Southgate J
Mol Cancer Res; 2008 Jan; 6(1):53-63. PubMed ID: 18234962
[TBL] [Abstract][Full Text] [Related]
18. Role of receptor complexes in the extranuclear actions of estrogen receptor alpha in breast cancer.
Song RX; Fan P; Yue W; Chen Y; Santen RJ
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S3-13. PubMed ID: 17259556
[TBL] [Abstract][Full Text] [Related]
19. Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide.
Price KA; Filiz G; Caragounis A; Du T; Laughton KM; Masters CL; Sharples RA; Hill AF; Li QX; Donnelly PS; Barnham KJ; Crouch PJ; White AR
Int J Biochem Cell Biol; 2008; 40(9):1901-17. PubMed ID: 18346929
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future.
Cohenuram M; Saif MW
JOP; 2007 Jan; 8(1):4-15. PubMed ID: 17228128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
